

          -  HIV infection

          -  Active hepatitis B infection.

          -  Renal failure with estimated glomerular filtration rate (GFR) < 60 ml/min) and
             patients on Hemodialysis.

          -  Osteoporosis

          -  Myasthenia gravis

          -  Pre-existent maculopathy.

          -  Retinitis pigmentosa

          -  Bradycardia < 50bpm

          -  Weight < 40kg

          -  Participant with any immunosuppressive condition or hematological disease

          -  Treatment with drugs that may prolong QT in the last month before randomization for
             more than 7 days including: azithromycin, chlorpromazine, cisapride, clarithromycin,
             domperidone, droperidol, erythromycin, halofantrine, haloperidol, lumefantrine,
             mefloquine, methadone, pentamidine, procainamide, quinidine, quinine, sotalol,
             sparfloxacin, thioridazine, amiodarone.

          -  Breastfeeding

          -  Known allergy to any of the medication used in this trial
      